[Skip to Content]
[Skip to Content Landing]
Views 130
Citations 0
Comment & Response
March 2017

Appropriate Treatment of T3 Glottic Cancer—Reply

Author Affiliations
  • 1Department of Otolaryngology–Head & Neck Surgery, Washington University in St Louis, St Louis, Missouri
 

Copyright 2016 American Medical Association. All Rights Reserved.

JAMA Otolaryngol Head Neck Surg. 2017;143(3):318. doi:10.1001/jamaoto.2016.3238

In Reply We thank Dr D’Ascanio and colleagues for their comments on our study.1 We agree on the points raised regarding heterogeneous subcategories within T3 glottic cancer category, failure to specify the type of surgery performed, and the challenges of reporting functional outcomes. We believe the fundamental issue is the incomplete nature of the data source with which we worked. Many of the important characteristics and variables described above were either not readily available or not reliable.

First Page Preview View Large
First page PDF preview
First page PDF preview
×